Abstract
N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) is a noradrenergic neurotoxin which selectively damages noradrenergic projections originating from the locus coeruleus (LC). DSP-4 treatment of rats on the first and third day after birth produces a long-lasting lesion of noradrenergic neurons in the prefrontal cortex (PFC). In DSP-4-lesioned rats, studied as adults, we observed a decrease in norepinephrine content, with no significant change in the levels of dopamine, 5-hydroxytryptamine, and γ-aminobutyric acid (GABA). There is now a well established interaction between noradrenergic and GABAergic systems, whereby the noradrenergic system is involved in the regulation of basal GABA release, while GABAergic neurons simultaneously exert tonic inhibitory regulation of LC norepinephrine neurons. We examined GABAergic neurotransmission in the norepinephrine-denervated PFC for a better appreciation of the interaction between these two systems. Treatment with the GABA transaminase inhibitor vigabatrine (VGB) increased the GABA level of PFC (tissue content) in both intact and lesioned groups. Additionally, VGB increased extracellular GABA concentration in the PFC in both control and DSP-4-lesioned animals, but the elevation of GABA was 2-fold higher in DSP-4 lesioned rats.
These findings indicate that neonatal DSP-4 treatment increases GABAergic neurotransmission in the PFC of rats in adulthood, perhaps by decreasing reactivity of central GABAA receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bortel A, J Dabrowska, P Nowak and R Brus (2004) Neonatal lesion of noradrenergic system and the central GABAergic system activity in adult rats.Pol. J. Pharmacol. 56, 100–101.
Dabrowska J, A Bortel, P Nowak and R Brus (2004) Reactivity of 5-HT1A receptors in rats with neonatal noradrenergic system lesion: behavioural studies.Pol. J. Pharmacol. 56, 105.
Del Arco A, G Segovia, K Fuxe and F Mora (2003) Changes in dialisate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions?J. Neurochem. 85, 23–33.
Jaim-Etcheverry G (1998) 2-Chloroethylamines (DSP-4 and Xylamine), In:Highly Selective Neurotoxins: Basic and Clinical Applications (Kostrzewa RM, Ed.) (Humana Press: Totowa, NJ), pp 131–140.
Jaim-Etcheverry G and LM Zieher (1980) DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats.Brain Res. 188, 513–523.
Jonsson G, H Hallman and E Sundstrom (1982) Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.Neuroscience 7, 2895–2907.
Kawahara Y, H Kawahara and BH Westerink (1999) Tonic regulation of the activity of noradrenergic neurons in the locus coeruleus of the conscious rat studied by dual-probe microdialysis.Brain Res. 823, 42–48.
Manns ID, MG Lee, M Modirrousta, YP Hou and BE Jones (2003) α2-Adrenergic receptors on GABAergic, putative sleep-promoting basal forebrain neurons.J. Neurosci. 18, 723–727.
Medina JH and ML Novas (1983) Parallel changes in brain flunitrazepam binding and density of noradrenergic innervation.Eur. J. Pharmacol. 88, 377–382.
Nowak P, L Labus, RM Kostrzewa and R Brus (2006) DSP-4 prevents dopamine receptor priming by quinpirole.Pharmacol. Biochem. Behav. 84, 3–7.
Ossowska K, J Wardas, M Smialowska, K Kuter, T Lenda, JM Wieronska, B Zieba, P Nowak, J Dabrowska, A Bortel, A Kwiecinski and S Wolfarth (2005) A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson’s disease?Eur. J. Neurosci. 22, 1294–1304.
Prieto M and MT Giralt (2001) Effects of DSP4 on α2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.Pharmacol. Toxicol. 88, 152–158.
Rowley HL, KF Martin and CA Marsden (1995) Determination ofin vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatization.J. Neurosci. Meth. 57, 93–99.
Sakamaki K, M Nomura, S Hatakenada, S Miyakubo and J Tanaka (2003) GABAergic modulation of noradrenaline release in the median preoptic nucleus area in the rat.Neurosci. Lett. 342(1-2), 77–80.
Sills GJ, E Butler, G Forrest, N Ratnajar, PN Patsalos and M Brodie (2003) Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.Epilepsia 44(7), 886–892.
Suzdak PD and G Gianutsos (1985) GABA-noradrenergic interaction: evidence for differential sites of action for GABA-A and GABA-B receptors.J. Neural Transm. 64, 163–172.
Trudeau L-E (2004) Glutamate co-transmission as an emerging concept in monoamine neuron function.J. Psychiatr. Neurosci. 29(4), 296–310.
Yu ZY, W Wang, JM Fritschy, OW Witte and C Redecker (2006) Changes in neocortical and hippocampal GABAA receptor subunit distribution during brain maturation and aging.Brain Res. 1099(1), 73–81.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bortel, A., Nowak, P. & Brus, R. Neonatal DSP-4 treatment modifies GABAergic neurotransmission in the prefrontal cortex of adult rats. neurotox res 13, 247–252 (2008). https://doi.org/10.1007/BF03033508
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033508